CORE LABS INC (CLB)
(Delayed Data from NYSE)
$18.37 USD
+0.26 (1.44%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $18.39 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.37 USD
+0.26 (1.44%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $18.39 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Zacks News
Oil Dips to 1-Year Low on Black Friday, Energy Stocks Suffer
by Zacks Equity Research
WTI crude prices tumbled 7.7% to $50.42 per barrel on Nov 23, marking the lowest settlement since October 2017.
Core Laboratories (CLB) Q3 Earnings & Revenues Top Estimates
by Zacks Equity Research
Core Laboratories' (CLB) third-quarter results are strongly favored by the Production Enhancement segment's notable performance.
Core Laboratories (CLB) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 1.59% and 2.46%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories (CLB) Q3 Earnings Preview: What to Expect
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for September 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Why Is Core Laboratories (CLB) Up 2.6% Since Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q2 Earnings In Line, Revenues Up Y/Y
by Zacks Equity Research
Core Laboratories' (CLB) second-quarter results are strongly favored by the Product Enhancement segment's notable performance.
Zacks Industry Outlook Highlights: Core Laboratories, C&J Energy Services, SEACOR Holdings and Mammoth Energy Services
by Zacks Equity Research
Zacks Industry Outlook Highlights: Core Laboratories, C&J Energy Services, SEACOR Holdings and Mammoth Energy Services
New Strong Sell Stocks for July 18th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
The Zacks Analyst Blog Highlights: Enbridge, Chevron, Core Laboratories N.V. and National Oilwell Varco
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Enbridge, Chevron, Core Laboratories N.V. and National Oilwell Varco
Oil & Gas Stock Roundup: Enbridge's Midstream Sale, Chevron's North Sea Plans & More
by Nilanjan Choudhury
Enbridge (ENB) is getting rid of assets in order to pare debt, while Chevron (CVX) is set to put a number of its oil and gas fields in Britain's North Sea for sale.
Company News For Jul 3, 2018
by Zacks Equity Research
Companies in the news are: CLB, ALKS, ACXM and URI
Core Labs (CLB) Slashes Q2 Guidance, Shares Plunge 13.6%
by Zacks Equity Research
Core Laboratories (CLB) expects total revenues in the band of $174-$175 million against the prior guided range of $177-$179 million.
Why Is Core Laboratories (CLB) Up 5.3% Since Its Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TechnipFMC (FTI) Q1 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
TechnipFMC's (FTI) total backlog stands at $14,012 million compared with $16,056.2 million a year ago, reflecting a decline of 12.7%.
TechnipFMC (FTI) to Report Q1 Earnings: Is a Beat in Store?
by Zacks Equity Research
TechnipFMC (FTI) is likely to deliver an earnings beat in the first quarter on cost containment initiatives along with strong project execution.
Core Laboratories (CLB) Q1 Earnings Meet Estimates, Up Y/Y
by Zacks Equity Research
Robust performance by Production Enhancement segment leads to higher year-over-year earnings and revenues for Core Laboratories (CLB).
Core Laboratories (CLB) Q4 Earnings & Revenues Meet Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivers improved year-over-year Q4 results on the back of solid performance from its Production Enhancement.
Why Is Core Laboratories (CLB) Up 15.1% Since the Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q3 Earnings & Revenues Top Estimates
by Zacks Equity Research
Despite being hit by hurricanes, Core Laboratories (CLB) reported better-than-expected third-quarter 2017 results. The results also improved year over year.
Oil Companies on Slippery Ground as Harvey Hampers Production
by Zacks Equity Research
The Harvey impact is evident on oil companies as some of them have already revised their guidance.
Core Laboratories (CLB) Down 17.7% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Strong Sell Stocks the Market Gave Up On
by David Bartosiak
With stocks coming under pressure, these five names are at lows and heading lower
Core Laboratories (CLB) Q2 Earnings Top Estimates, Sales Lag
by Zacks Equity Research
Core Laboratories N.V. (CLB) surpassed earnings estimates in the second quarter due to higher operating income and revenues in the product enhancement segment.
Peek Into Oil Q2 Earnings on Jul 24: HAL, APC & CLB
by Nilanjan Choudhury
Of the 16 Zacks sectors, energy is expected to report the highest year-over-year earnings growth in Q2.